Meetings: Advisory Committees; Tentative Schedule (for 2010)

Federal Register: December 30, 2009 (Volume 74, Number 249)

Notices

Page 69119-69122

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr30de09-80

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Docket No. FDA-2009-N-0664

Advisory Committees; Tentative Schedule of Meetings for 2010

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

SUMMARY: The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory

Page 69120

committees for 2010. During 1991, at the request of the Commissioner of

Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register.

This publication implements the IOM's recommendation.

FOR FURTHER INFORMATION CONTACT: Teresa L. Hays, Advisory Committee

Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, undertook a study of the use of the FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings.

Because the schedule is tentative amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/AdvisoryCommittees/default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2010. You may also obtain up-to-date information by calling the Advisory Committee Information Line, 1-800-741-8138

(301-443-0572 in the Washington, DC area) and use the appropriate

Information Line Code for the committee in which you are interested.

Advisory

Tentative Date of

Committee 10-

Committee Name

Meeting(s)

Digit Information

Line Code

OFFICE OF THE COMMISSIONER

Pediatric Advisory

March 22, June 21-22,

8732310001

Committee

September 20-21,

December 6-7

Risk Communication

February 25-26, May 6-7,

8732112560

Advisory Committee

August 19-20, November 8- 9

Science Board to the

February 22, May 17,

3014512603

Food and Drug

August 16, November 15

Administration

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

Allergenic Products

April 30, October 26

3014512388

Advisory Committee

Blood Products Advisory April 12-13, July 26-27,

3014519516

Committee

November 18-19

Cellular, Tissue and

To be announced

3014512389

Gene Therapies Advisory

Committee

Transmissible Spongiform To be announced

3014512392

Encephalopathies

Advisory Committee

Vaccines and Related

February 22, May 19-20,

3014512391

Biological Products

September 15-16,

Advisory Committee

November 17-18

CENTER FOR DRUG EVALUATION AND RESEARCH

Anesthetic and Life

January 28, April 22,

3014512529

Support Drugs Advisory

April 23

Committee

Anti Infective Drugs

August and October dates

3014512530

Advisory Committee

To be announced

Antiviral Drugs Advisory To be announced

3014512531

Committee

Arthritis Advisory

May dates To be announced

3014512532

Committee

Cardiovascular and Renal January 11, March 1,

3014512533

Drugs Advisory

April dates to be

Committee

announced, July 28, July 29, December 8, December 9

Dermatologic and

To be announced

3014512534

Ophthalmic Drugs

Advisory Committee

Drug Safety and Risk

To be announced

3014512535

Management Advisory

Committee

Endocrinologic and

January 12, January 13,

3014512536

Metabolic Drugs

February 24, May 26-27

Advisory Committee

Gastrointestinal Drugs

February 23, November

3014512538

Advisory Committee

dates to be announced

Nonprescription Drugs

To be announced

3014512541

Advisory Committee

Oncologic Drugs Advisory February 10, May 4, May

3014512542

Committee

5, July 20, July 21,

September 1, September 2, December 1, December 2

Page 69121

Peripheral and Central

March 23, March 24, June

3014512543

Nervous System Drugs

dates to be announced

Advisory Committee

Pharmaceutical Science

March 17

3014512539 and Clinical

Pharmacology, Advisory

Committee

Psychopharmacologic

To be announced

3014512544

Drugs Advisory

Committee

Pulmonary Allergy Drugs March 9, March 10, April

3014512545

Advisory Committee

dates to be announced

Reproductive Health

May dates to be announced

3014512537

Drugs, Advisory

Committee

CENTER FOR DEVICES AND RADIOLOGICAL HEALTH

Device Good

July 22, September 16

3014512398

Manufacturing Practice

Advisory Committee

Medical Devices Advisory Committee (Comprised of 18 Panels)

Anesthesiology and

April 30, June 23,

3014512624

Respiratory Therapy

September 15, November

Devices Panel

10

Circulatory System

February 25, May 27,

3014512625

Devices Panel

September 23, December 8- 9

Clinical Chemistry and

March 17-18, June 16-17,

3014512514

Clinical Toxicology

October 20-21

Devices Panel

Dental Products Panel

March 23, April 13, May

3014512518 11, July 13, September 14

Ear, Nose, and Throat

February 24, May 19,

3014512522

Devices Panel

August 25, November 3-4

Gastroenterology-Urology March 11-12, June 17-18,

3014512523

Devices Panel

September 9-10, December 2-3

General and Plastic

February 4-5, May 20-21,

3014512519

Surgery Devices Panel

August 12-13, November 4- 5

General Hospital and

March 5, July 28-29,

3014512520

Personal Use Devices

November 17-18

Panel

Hematology and Pathology January 21-22, April 22-

3014512515

Devices Panel

23, July 8-9, October 21- 22

Immunology Devices Panel April 26, September 15,

3014512516

December 6

Medical Devices Dispute Meetings occur as needed

3014510232

Resolution Panel

Microbiology Devices

March 19, September 23

3014512517

Panel

Molecular and Clinical

April 15, October 5-6

3014510231

Genetics Panel

Neurological Devices

March 11-12, May 13-4,

3014512513

Panel

July 8-9, October 7-8,

December 9-10

Obstetrics and

April 22-23, July 15-16,

3014512524

Gynecology Devices

October 21-22, December

Panel

16-17

Ophthalmic Devices Panel February 25-26, April 22-

3014512396 23, June 24-25, October 28-29, November 18-19

Orthopedic and

March 23, June 9-10,

3014512521

Rehabilitation Devices

October 13-14, December

Panel

1-2

Radiological Devices

April 28, July 21,

3014512526

Panel

September 15, November 17

National Mammography

January 25

3014512397

Quality Assurance

Advisory Committee

Technical Electronic

No meeting tentatively

3014512399

Product Radiation

scheduled for 2010

Safety Standards

Committee

CENTER FOR FOOD SAFETY AND APPLIED NUTRITION

Food Advisory Committee May 20-21

3014510564

CENTER FOR VETERINARY MEDICINE

Veterinary Medicine

March 18-19

3014512548

Advisory Committee

NATIONAL CENTER FOR TOXILOGICAL RESEARCH (NCTR)

Page 69122

Science Advisory Board

November 17-18

3014512559 to NCTR

Center for Tobacco

Tobacco Products

March, May, July, and

8732110002

Scientific Advisory

November dates to be

Committee

announced

Dated: December 24, 2009.

David Horowitz,

Assistant Commissioner for Policy.

FR Doc. E9-30973 Filed 12-29-09; 8:45 am

BILLING CODE 4160-01-S